Benitec Biopharma (BNTC) Operating Leases (2019 - 2025)
Historic Operating Leases for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $613000.0.
- Benitec Biopharma's Operating Leases rose 7316.38% to $613000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $613000.0, marking a year-over-year increase of 7316.38%. This contributed to the annual value of $284000.0 for FY2024, which is 4919.5% down from last year.
- Latest data reveals that Benitec Biopharma reported Operating Leases of $613000.0 as of Q1 2025, which was up 7316.38% from $137000.0 recorded in Q4 2024.
- Benitec Biopharma's Operating Leases' 5-year high stood at $954000.0 during Q3 2021, with a 5-year trough of $137000.0 in Q4 2024.
- For the 5-year period, Benitec Biopharma's Operating Leases averaged around $538058.8, with its median value being $559000.0 (2023).
- Per our database at Business Quant, Benitec Biopharma's Operating Leases skyrocketed by 28075.12% in 2022 and then tumbled by 6761.23% in 2024.
- Benitec Biopharma's Operating Leases (Quarter) stood at $911000.0 in 2021, then decreased by 24.81% to $685000.0 in 2022, then plummeted by 38.25% to $423000.0 in 2023, then plummeted by 67.61% to $137000.0 in 2024, then skyrocketed by 347.45% to $613000.0 in 2025.
- Its Operating Leases was $613000.0 in Q1 2025, compared to $137000.0 in Q4 2024 and $211000.0 in Q3 2024.